探讨脑脉康方治疗脑动脉硬化症的临床观察  

Clinical observation of Naomaikang Treatment in treating cerebral arteriosclerosis

作　　者：杨阳[1] 

机构地区：[1]日照市人民医院,山东日照276800

出　　处：《中医临床研究》2016年第18期54-55,共2页Clinical Journal Of Chinese Medicine

摘　　要：目的:探究脑动脉硬化症的临床诊治中,采用脑脉康方药物进行诊治,观察其临床应用效果。方法:选取2014年3月—2015年9月本院接受诊治的80例脑动脉硬化症患者作为研究的案例,根据随机数字表法,将其划分为探究组和比较组,每组40例,比较组患者给予镇脑宁药物治疗,探究组患者给予脑脉康方药物进行诊治,对比两组患者疗效。结果:探究组患者给予脑脉康方药物进行诊治后,其疾病治疗的总有效率高达95.0%;比较组患者给予镇脑宁药物治疗后,其疾病治疗的总有效率达到85.0%。同时在中医证候积分方面,探究组患者相较于比较组患者,有显著差异,具有统计学意义(P<0.05)。结论:在脑动脉硬化症的临床诊治中,采用脑脉康方药物进行诊治,具有良好的治疗效果,不仅能有效地提升疾病治疗总有效率,还能有效地缓解患者的中医证候,改善患者的身心健康状况。Objective: To explore the clinical diagnosis and treatment effect of Naomaikang treatmen in treating cerebralatherosclerosis. Methods: 80 patients with cerebral palsy atherosclerosis, admitted to our hospital from March 2014 to September 2015,were selected as research objects and randomLy divided into the observation group and the control group, with40 cases in each group. Thecontrol group received Zhennaoning treatment while the observation group received Naomaikang treatmen, efficacy of two groups werecompared. Results: The total effective rate of the observation group was as high as 95.0% after being given Naomaikang treatmen whilethat of the control group was 85.0% after being given Zhennaoning treatment; the TCM syndrome score of the observation group was betterthan that of the control group, the difference was of statistical significance (P<0.05). Conclusion: Naomaikang treatmen had bettertherapeutic effect in clinical diagnosis and treatment of cerebral atherosclerosis; it could improve the total effective rate effectively inaddition to relieving the patients’ TCM syndrome efficiently and improve the patients’ physical and mental health.

关 键 词：脑脉康方 脑动脉硬化症 临床观察 

分 类 号：R255.2[医药卫生—中医内科学]